S. Ascioglu, J. Rex, B. De-pauw, J. Bennett, J. Bille et al., Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus, Clinical Infectious Diseases, vol.34, issue.1, pp.7-14, 2002.
DOI : 10.1086/323335

J. Caston-osorio, A. Rivero, and J. Torre-cisneros, Epidemiology of invasive fungal infection, International Journal of Antimicrobial Agents, vol.32, pp.103-112, 2008.
DOI : 10.1016/S0924-8579(08)70009-8

C. Kibbler, Defining invasive fungal infections in neutropenic or stem cell transplant patients, Journal of Antimicrobial Chemotherapy, vol.56, issue.suppl 1, pp.12-18, 2005.
DOI : 10.1093/jac/dki219

F. Jr, P. Sobel, and J. , Immunopathogenesis of recurrent vulvovaginal candidiasis, Clin Microbiol Rev, vol.9, issue.3, pp.335-383, 1996.

E. Ringdahl, Recurrent vulvovaginal candidiasis, Mol Med, vol.103, issue.2, pp.165-173, 2006.

J. Sobel, Pathogenesis and Treatment of Recurrent Vulvovaginal Candidiasis, Clinical Infectious Diseases, vol.14, issue.Supplement 1, pp.148-53, 1992.
DOI : 10.1093/clinids/14.Supplement_1.S148

J. Sobel, Pathogenesis of recurrent vulvovaginal candidiasis, Current Infectious Disease Reports, vol.162, issue.6, pp.514-523, 2002.
DOI : 10.1007/s11908-002-0038-7

J. Spacek, V. Buchta, P. Jilek, and M. Forstl, Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.131, issue.2, pp.198-202, 2007.
DOI : 10.1016/j.ejogrb.2006.03.009

F. Jr, P. Lynch, M. Conaway, D. Tait, L. Sobel et al., Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity, Infect Immun, vol.63, issue.2, pp.547-53, 1995.

J. Leigh, M. Barousse, R. Swoboda, T. Myers, S. Hager et al., ???Specific Systemic Cell???Mediated Immune Reactivities in Human Immunodeficiency Virus???Positive Persons with Mucosal Candidiasis, The Journal of Infectious Diseases, vol.183, issue.2, pp.277-85, 2001.
DOI : 10.1086/317944

M. Lynch, J. Sobel, F. Jr, and P. , Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis, Medical Mycology, vol.34, issue.5, pp.337-346, 1996.
DOI : 10.1080/02681219680000571

J. Sobel, Management of Patients with Recurrent Vulvovaginal Candidiasis, Drugs, vol.126, issue.11, pp.1059-66, 2003.
DOI : 10.2165/00003495-200363110-00002

J. Sobel, H. Wiesenfeld, M. Martens, P. Danna, T. Hooton et al., Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis, New England Journal of Medicine, vol.351, issue.9, pp.876-83, 2004.
DOI : 10.1056/NEJMoa033114

F. Jr and P. , The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models, Int Rev Immunol, vol.21, issue.6, pp.515-563, 2002.

F. Jr and P. , Immunity in vaginal candidiasis, Curr Opin Infect Dis, vol.18, issue.2, pp.107-118, 2005.

F. Jr, P. Luo, W. Steele, C. Chabain, J. Baker et al., Analysis of vaginal cell populations during experimental vaginal candidiasis, Infect Immun, vol.67, issue.6, pp.3135-3175, 1999.

O. Babula, G. Lazdane, J. Kroica, W. Ledger, and S. Witkin, Relation between Recurrent Vulvovaginal Candidiasis, Vaginal Concentrations of Mannose-Binding Lectin, and a Mannose-Binding Lectin Gene Polymorphism in Latvian Women, Clinical Infectious Diseases, vol.37, issue.5, pp.733-740, 2003.
DOI : 10.1086/377234

O. Babula, G. Lazdane, J. Kroica, I. Linhares, W. Ledger et al., Frequency of Interleukin-4 (IL-4) -589 Gene Polymorphism and Vaginal Concentrations of IL-4, Nitric Oxide, and Mannose-Binding Lectin in Women with Recurrent Vulvovaginal Candidiasis, Clinical Infectious Diseases, vol.40, issue.9, pp.1258-62, 2005.
DOI : 10.1086/429246

W. Chaim, B. Foxman, and J. Sobel, Association of Recurrent Vaginal Candidiasis and Secretory ABO and Lewis Phenotype, The Journal of Infectious Diseases, vol.176, issue.3, pp.828-858, 1997.
DOI : 10.1086/517314

F. Jr and P. , History and update on host defense against vaginal candidiasis, Am J Reprod Immunol, vol.57, issue.1, pp.2-12, 2007.

D. Bernardis, F. Adriani, D. Lorenzini, R. Pontieri, E. Carruba et al., Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection, Infect Immun, vol.61, issue.4, pp.1500-1508, 1993.

D. Bernardis, F. Boccanera, M. Adriani, D. Spreghini, E. Santoni et al., Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats, Infect Immun, vol.65, issue.8, pp.3399-405, 1997.

D. Bernardis, F. Liu, H. , O. Mahony, R. et al., Inhibit Fungus Adherence to Vaginal Epithelium and Protect against Experimental Vaginal Candidiasis, The Journal of Infectious Diseases, vol.195, issue.1, pp.149-57, 2007.
DOI : 10.1086/509891

URL : https://hal.archives-ouvertes.fr/hal-00464705

D. Bernardis, F. Agatensi, L. Ross, I. Emerson, G. Lorenzini et al., Evidence for a Role for Secreted Aspartate Proteinase of Candida albicans in Vulvovaginal Candidiasis, Journal of Infectious Diseases, vol.161, issue.6, pp.1276-83, 1990.
DOI : 10.1093/infdis/161.6.1276

A. Cassone, D. Bernardis, F. Santoni, and G. , Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention, Infection and Immunity, vol.75, issue.10, pp.4675-86, 2007.
DOI : 10.1128/IAI.00083-07

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2044548

A. Cassone and A. Torosantucci, Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine, Expert Review of Vaccines, vol.5, issue.6, pp.859-67, 2006.
DOI : 10.1586/14760584.5.6.859

D. Bernardis, F. Boccanera, M. Adriani, D. Girolamo, A. Cassone et al., Intravaginal and Intranasal Immunizations Are Equally Effective in Inducing Vaginal Antibodies and Conferring Protection against Vaginal Candidiasis, Infection and Immunity, vol.70, issue.5, pp.2725-2734, 2002.
DOI : 10.1128/IAI.70.5.2725-2729.2002

M. Moragues, M. Omaetxebarria, N. Elguezabal, M. Sevilla, S. Conti et al., A Monoclonal Antibody Directed against a Candida albicans Cell Wall Mannoprotein Exerts Three Anti-C. albicans Activities, Infection and Immunity, vol.71, issue.9, pp.5273-5282, 2003.
DOI : 10.1128/IAI.71.9.5273-5279.2003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC187351

L. Polonelli, D. Bernadis, F. Conti, S. Boccanera, M. Magliani et al., Human natural yeast killer toxin-like candidacidal antibodies, J Immunol, vol.156, issue.5, pp.1880-1885, 1996.

L. Polonelli, D. Bernardis, F. Conti, S. Boccanera, M. Gerloni et al., Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies, J Immunol, vol.152, issue.6, pp.3175-82, 1994.

L. Polonelli, W. Magliani, S. Conti, L. Bracci, L. Lozzi et al., Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis, Infection and Immunity, vol.71, issue.11, pp.6205-6217, 2003.
DOI : 10.1128/IAI.71.11.6205-6212.2003

G. Santoni, M. Boccanera, D. Adriani, R. Lucciarini, C. Amantini et al., Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4+ T Cells and Possible Participation of Other Local Lymphocyte Effectors, Infection and Immunity, vol.70, issue.9, pp.4791-4798, 2002.
DOI : 10.1128/IAI.70.9.4791-4797.2002

A. Torosantucci, C. Bromuro, P. Chiani, D. Bernardis, F. Berti et al., A novel glyco-conjugate vaccine against fungal pathogens, The Journal of Experimental Medicine, vol.14, issue.5, pp.597-606, 2005.
DOI : 10.1099/00222615-27-4-233

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212864

F. De-bernardis, G. Santoni, M. Boccanera, E. Spreghini, D. Adriani et al., Local Anticandidal Immune Responses in a Rat Model of Vaginal Infection by and Protection against Candida albicans, Infection and Immunity, vol.68, issue.6, pp.3297-304, 2000.
DOI : 10.1128/IAI.68.6.3297-3304.2000

F. Jr, P. Lynch, M. Sobel, and J. , Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis, Infect Immun, vol.61, issue.5, pp.1990-1995, 1993.

M. Hamad, E. Muta-'eb, Q. Abu-shaqra, A. Fraij, K. Abu-elteen et al., Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection, Mycoses, vol.116, issue.2, pp.104-112, 2006.
DOI : 10.1046/j.1365-2249.2003.02032.x

B. Enjalbert, A. Rachini, G. Vediyappan, D. Pietrella, R. Spaccapelo et al., A Multifunctional, Synthetic Gaussia princeps Luciferase Reporter for Live Imaging of Candida albicans Infections, Infection and Immunity, vol.77, issue.11, pp.4847-58, 2009.
DOI : 10.1128/IAI.00223-09

A. Torosantucci, P. Chiani, C. Bromuro, D. Bernardis, F. Palma et al., Protection by Anti-??-Glucan Antibodies Is Associated with Restricted ??-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence, PLoS ONE, vol.64, issue.7, p.5392, 2009.
DOI : 10.1371/journal.pone.0005392.s002

E. Moreno-ruiz, G. Ortu, P. De-groot, F. Cottier, C. Loussert et al., The GPI-modified proteins Pga59 and Pga62 of Candida albicans are required for cell wall integrity, Microbiology, vol.155, issue.6, pp.2004-2024, 2009.
DOI : 10.1099/mic.0.028902-0

B. Tannous, D. Kim, J. Fernandez, R. Weissleder, and X. Breakefield, Codon-Optimized Gaussia Luciferase cDNA for Mammalian Gene Expression in Culture and in Vivo, Molecular Therapy, vol.11, issue.3, pp.435-478, 2005.
DOI : 10.1016/j.ymthe.2004.10.016

M. Raska, J. Belakova, M. Horynova, M. Krupka, J. Novotny et al., hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis, Medical Mycology, vol.46, issue.5, pp.411-431, 2008.
DOI : 10.1080/13693780701883508

M. Saavedra, B. Taylor, N. Lukacs, F. Jr, and P. , Local production of chemokines during experimental vaginal candidiasis, Infect Immun, vol.67, issue.11, pp.5820-5826, 1999.

C. Steele, H. Ozenci, W. Luo, M. Scott, F. Jr et al., Growth inhibition of Candida albicans by vaginal cells from na??ve mice, Medical Mycology, vol.37, issue.4, pp.251-260, 1999.
DOI : 10.1046/j.1365-280X.1999.00228.x

K. Wozniak, W. Jr, F. , F. Jr, and P. , Candida-Specific Antibodies during Experimental Vaginal Candidiasis in Mice, Infection and Immunity, vol.70, issue.10, pp.5790-5799, 2002.
DOI : 10.1128/IAI.70.10.5790-5799.2002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC128320

D. Bernardis, F. Lucciarini, R. Boccanera, M. Amantini, C. Arancia et al., Phenotypic and Functional Characterization of Vaginal Dendritic Cells in a Rat Model of Candida albicans Vaginitis, Infection and Immunity, vol.74, issue.7, pp.4282-94, 2006.
DOI : 10.1128/IAI.01714-05

M. Yordanov, P. Dimitrova, S. Danova, and N. Ivanovska, Candida albicans double-stranded DNA can participate in the host defense against disseminated candidiasis, Microbes and Infection, vol.7, issue.2, pp.178-86, 2005.
DOI : 10.1016/j.micinf.2004.10.011

D. Bailey, P. Feldmann, M. Bovey, N. Gow, and A. Brown, The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins., Journal of Bacteriology, vol.178, issue.18, pp.5353-60, 1996.
DOI : 10.1128/jb.178.18.5353-5360.1996

L. Hoyer, T. Payne, M. Bell, A. Myers, and S. Scherer, Candida albicans ALS3 and insights into the nature of the ALS gene family, Current Genetics, vol.33, issue.6, pp.451-460, 1998.
DOI : 10.1007/s002940050359

Q. Phan, C. Myers, Y. Fu, D. Sheppard, M. Yeaman et al., Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells, PLoS Biology, vol.2, issue.3, p.64, 2007.
DOI : 10.1371/journal.pbio.0050064.sg003

URL : http://doi.org/10.1371/journal.pbio.0050064

O. Hagan and D. , MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection, Expert Rev Vaccines, vol.6, issue.5, pp.699-710, 2007.

G. Galli, D. Medini, E. Borgogni, L. Zedda, M. Bardelli et al., Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels, Proceedings of the National Academy of Sciences, vol.21, issue.1, pp.3877-82, 2009.
DOI : 10.1146/annurev.immunol.21.120601.141142

D. Granoff, Y. Mchugh, H. Raff, A. Mokatrin, and G. Van-nest, MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine, Infect Immun, vol.65, issue.5, pp.1710-1715, 1997.